• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mounting evidence for lack of PCI benefit in stable ischemic heart disease : what more will it take to turn the tide of treatment?: comment on "initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease".

作者信息

Boden William E

机构信息

Department of Medicine, Albany Medical Center, Albany, New York, NY, USA.

出版信息

Arch Intern Med. 2012 Feb 27;172(4):319-21. doi: 10.1001/archinternmed.2011.2321.

DOI:10.1001/archinternmed.2011.2321
PMID:22371920
Abstract
摘要

相似文献

1
Mounting evidence for lack of PCI benefit in stable ischemic heart disease : what more will it take to turn the tide of treatment?: comment on "initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease".稳定型缺血性心脏病患者接受经皮冠状动脉介入治疗（PCI）无获益的证据越来越多：要扭转治疗趋势还需要什么？：对“稳定型冠状动脉疾病初始冠状动脉支架植入联合药物治疗与单纯药物治疗对比”的评论
Arch Intern Med. 2012 Feb 27;172(4):319-21. doi: 10.1001/archinternmed.2011.2321.
2
Informed strategies for treating coronary disease: comment on "initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease".治疗冠心病的明智策略：对“稳定型冠状动脉疾病的初始冠状动脉支架植入术联合药物治疗与单纯药物治疗”的评论
Arch Intern Med. 2012 Feb 27;172(4):321. doi: 10.1001/archinternmed.2011.2313.
3
Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.初始冠状动脉支架植入术联合药物治疗与单纯药物治疗用于稳定型冠状动脉疾病：随机对照试验的荟萃分析
Arch Intern Med. 2012 Feb 27;172(4):312-9. doi: 10.1001/archinternmed.2011.1484.
4
Stenting vs medical therapy for stable coronary artery disease: a minefield for meta-analyses?支架置入术与药物治疗用于稳定型冠状动脉疾病：荟萃分析的雷区？
Arch Intern Med. 2012 Jul 9;172(13):1044; author reply 1044-5. doi: 10.1001/archinternmed.2012.1874.
5
Percutaneous coronary intervention for stable coronary artery disease: the debate continues.
Arch Intern Med. 2012 Jul 9;172(13):1043-4. doi: 10.1001/archinternmed.2012.1753.
6
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.临界血流储备分数指导下的经皮冠状动脉介入治疗与稳定型冠心病的药物治疗。
N Engl J Med. 2012 Sep 13;367(11):991-1001. doi: 10.1056/NEJMoa1205361. Epub 2012 Aug 27.
7
Optimal medical therapy with or without PCI for stable coronary disease.稳定型冠心病接受或不接受经皮冠状动脉介入治疗的优化药物治疗
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
8
Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.药物涂层球囊血管成形术治疗冠状动脉疾病初发病变的临床价值
Int J Cardiol. 2016 Nov 1;222:113-118. doi: 10.1016/j.ijcard.2016.07.156. Epub 2016 Jul 27.
9
[Strategy for patients with low-risk coronary artery disease: initial medical therapy only or PCI plus medical therapy].[低风险冠状动脉疾病患者的治疗策略：仅初始药物治疗还是PCI联合药物治疗]
Nihon Rinsho. 2011 Feb;69(2):253-8.
10
Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.经皮冠状动脉介入治疗联合药物治疗比单纯初始药物治疗能更有效地降低低危冠状动脉疾病患者急性冠状动脉综合征的发生率：一项随机、对照、多中心研究。
JACC Cardiovasc Interv. 2008 Oct;1(5):469-79. doi: 10.1016/j.jcin.2008.08.002.

引用本文的文献

1
Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China.肺部疾病患者肿瘤标志物不恰当使用的程度及费用：中国上海的一项多中心回顾性研究
BMJ Open. 2018 Feb 28;8(2):e019051. doi: 10.1136/bmjopen-2017-019051.
2
The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.“易损斑块”的神话：从关注个体病变转向以动脉粥样硬化疾病负担进行冠状动脉疾病风险评估。
J Am Coll Cardiol. 2015 Mar 3;65(8):846-855. doi: 10.1016/j.jacc.2014.11.041. Epub 2015 Jan 16.
3
Invasive and non-invasive fractional flow reserve index in validation of hemodynamic severity of intracoronary lesions.
有创和无创血流储备分数指数在冠状动脉内病变血流动力学严重程度验证中的应用
Postepy Kardiol Interwencyjnej. 2013;9(2):160-9. doi: 10.5114/pwki.2013.35452. Epub 2013 Jun 17.
4
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.残余心血管风险的分子来源、临床信号及创新解决方案：与亚临床疾病、治疗不足及依从性差的关系：新证据对优化心血管疾病患者预后的影响
Vasc Health Risk Manag. 2013;9:617-70. doi: 10.2147/VHRM.S37119. Epub 2013 Oct 21.
5
Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease. Lessons from the COURAGE and FAME 2 trials.心肌缺血对稳定型缺血性心脏病心肌血运重建的影响。来自COURAGE和FAME 2试验的经验教训。
Herz. 2013 Jun;38(4):382-6. doi: 10.1007/s00059-013-3824-0.
6
Myocardial Revascularization in New York State: Variations in the PCI-to-CABG Ratio and Their Implications.纽约州的心肌血管重建术：PCI 与 CABG 比例的变化及其意义。
J Am Heart Assoc. 2012 Apr;1(2):e001446. doi: 10.1161/JAHA.112.001446. Epub 2012 Apr 24.